Miconia albicans and Curcuma longa herbal medicines positively modulate joint pain, function and inflammation in patients with osteoarthritis: a clinical study
- PMID: 33452967
- DOI: 10.1007/s10787-020-00781-9
Miconia albicans and Curcuma longa herbal medicines positively modulate joint pain, function and inflammation in patients with osteoarthritis: a clinical study
Abstract
This study aims to evaluate the analgesic and modulating effect of Curcuma longa and Miconia albicans herbal medicines in knee's osteoarthritis (OA) treatment. This longitudinal study evaluated 24 patients with OA. The patients were divided into three groups: ibuprofen (1200 mg/day), C. longa (1000 mg/day) and M. albicans (1000 mg/day). The medications were applied orally for 30 days. The synovial fluid of the knee joint was collect at the first (day 0) and the last medical (day 30) consultation. The groups treated with herbal medicines presented the same results when compared to Ibuprofen. The comparison of the means of Total WOMAC for M. albicans before and after treatment presented a statistically significant difference (mean day 0 = 57.19; mean day 30 = 31.02) as well as variation of Total WOMAC for C. longa (mean day 0 = 54.79; mean day 30 = 37.08). The WOMAC Total and the VASP were compared, it was found that there was a significant decrease in the means in the C. longa and M. albicans groups, as well as in the Ibuprofen group after treatment. The study demonstrated that the treatment of knee OA with C. longa or M. albicans positively interferes with patients pain and functionality, decreased WOMAC and VASP scores, leading to functional improvement of these patients. This is the first clinical study demonstrating the analgesic and anti-inflammatory effect on knee osteoarthritis from M. albicans comparable to Ibuprofen drug.
Keywords: Curcuma longa; Ibuprofen; Inflammatory mediators; Knee osteoarthritis; Miconia albicans; Pain measurement.
References
-
- Aborehab NM, El Bishbishy MH, Refaiy A, Waly NE (2017) A putative chondroprotective role for IL-1β and MPO in herbal treatment of experimental osteoarthritis. BMC Complem Altern M 17:495 - DOI
-
- Adamczak A, Ozarowski M, Karpinski TM (2020) Curcumin, a natural antimicrobial agent with strain-specific activity. Pharmaceuticals 13:153–165 - DOI
-
- Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol.
-
- Coelho MR, Romi MD, Ferreira DMTP, Zaltman C, Soares-Mota M (2020) The use of Curcumin as a complementary therapy in ulcerative colitis: a systematic review of randomized controlled clinical trials. Nutrients 12:2296–2308 - DOI
-
- Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, Pottie P (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48:3118–3129 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical